Florida Researchers Still Weighing Hurricane Losses

Two months after Andrew unleashed its devastating fury, scientists continue to assess the damage the storm caused to their lives and laboratory endeavors Eight weeks have passed since Hurricane Andrew cut its devastating swath across South Florida, and public officials are still in the process of assessing the damage its winds and waves wrought in terms of fatalities, property loss, and shattered human lives. Scientists working and living in Andrew's path were by no means spared, for the ra

Written byRicki Lewis
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Scientists working and living in Andrew's path were by no means spared, for the ravaging storm, which struck in the early hours of August 24, played no favorites.

Current estimates are that Andrew--with gusts in excess of 175 miles per hour welling up against a backdrop of sustained winds of 145 mph--left behind 350,000 newly homeless people and at least $30 billion in damage.

Perhaps most tragic to scientific researchers was the damage sustained by South Florida's fragile ecosystems, such as Everglades National Park and coral reefs in Biscayne National Park, considered by life scientists to be among the greatest natural laboratories in the world.

Fairchild Tropical Garden, a large facility growing tropical plants, also was dealt a severe blow. The garden's location between Miami and Homestead placed the palms and cycads, many of them endangered species, directly in the storm's path. Teams of botanists from throughout the United States ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies